GlaxoSmithKline related Press Releases
NICE upholds GSK appeal for advanced breast cancer treatment, Tyverb® (lapatinib)
GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
GSK announces a strategic alliance with Dr. Reddy's to further accelerate sales growth in emerging markets
Orexigen Therapeutics, Inc. Announces In-Licensing of Key Patents from GlaxoSmithKline (GSK)
Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
GSK extends strategic collaboration with Aspen
GSK extends strategic collaboration with Aspen - GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manufacturing facility in Bad Oldesloe, Germany -
... Read more...Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009 Data Include First Presentation of Phase III Progression Free Survival Results for Pazopanib in Kidney
... Read more...New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical
... Read more...GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million Issued: Wednesday 6th May 2009, Research Triangle Park, NC GlaxoSmithKline plc (GSK) today announced that it
... Read more...Emergence of a new H1N1 influenza A strain (swine influenza)
Emergence of a new H1N1 influenza A strain (swine influenza) Issued: Monday 27 April 2009, London UK GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new
... Read more...Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




